nimodipine has been researched along with Heart Failure in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheikh-Hamad, D | 1 |
| Bick, R | 1 |
| Wu, GY | 1 |
| Christensen, BM | 1 |
| Razeghi, P | 1 |
| Poindexter, B | 1 |
| Taegtmeyer, H | 1 |
| Wamsley, A | 1 |
| Padda, R | 1 |
| Entman, M | 1 |
| Nielsen, S | 1 |
| Youker, K | 1 |
1 other study available for nimodipine and Heart Failure
| Article | Year |
|---|---|
Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Coronary Vess | 2003 |